Subsidy Tracker Parent Company Summary

Parent Company Name: 
Emergent BioSolutions
Ownership Structure: 
publicly traded (ticker symbol EBS)
Headquartered in: 
Maryland
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$11,976,50019
Federal (grants and allocated tax credits)$00
TOTAL$11,976,50019
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$00
Time Period for State and Local Awards: 

Earliest year of data: 2005. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2012.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

CANGENE BIOPHARMA; EMERGENT BIOSOLUTIONS; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG; EMERGENT PRODUCT DEVELOPMENT SEATTLE


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
Michigan$7,708,3693
Maryland$3,499,3778
Washington$768,7548

Individual Subsidy Records:

Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
Emergent Biosolutions Michigan state 2009 $3,090,000 tax credit/rebate
Emergent Biosolutions Michigan state 2012 $2,821,980 tax increment financing
Emergent BioSolutions Inc. Maryland state 2015 $2,000,000 grant/loan hybrid program
Emergent Biosolutions Michigan state 2012 $1,796,389 tax increment financing
EMERGENT BIOSOLUTIONS INC Maryland local 2014 $750,000 grant/loan hybrid program
Emergent Biosolutions Maryland local 2013 $495,000 grant
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC Washington state 2011 $207,108 tax credit/rebate
Emergent Biosolutions Inc. Maryland state 2014 $103,503 tax credit/rebate
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC Washington state 2012 $101,569 tax credit/rebate
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC Washington state 2011 $91,754 tax credit/rebate
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC Washington state 2010 $91,754 tax credit/rebate
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC Washington state 2014 $83,367 tax credit/rebate
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC Washington state 2014 $83,218 tax credit/rebate
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC Washington state 2013 $62,739 tax credit/rebate
Emergent Biosolutions, Inc. Maryland state 2016 $53,219 tax credit/rebate
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC Washington state 2012 $47,245 tax credit/rebate
Emergent Product Development Gaithersburg, Inc. Maryland state 2005 $34,357 tax credit/rebate
Emergent Biosolutions, Inc. Maryland state 2017 $32,037 tax credit/rebate
Emergent Product Development Gaithersburg, Inc. Maryland state 2008 $31,261 tax credit/rebate
Emergent BioSolutions Maryland local 2009 undisclosed grant
Cangene bioPharma, Inc. Maryland local 2009 undisclosed enterprise zone
Download results as CSV or XML